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1. Introduction 
Glaucoma is a complex disease that comprises a group of heterogeneous optic neuropathies 
characterized by a progressive degeneration of the optic nerve head and visual field defects. 
It starts with unnoticeable blind spots at the edges of field vision progressing to the tunnel 
vision and finally leading to blindness (Quigley & Broman, 2006). The disease process is 
insidious, and the central vision is usually not lost until the disease is advanced, a significant 
proportion of individuals remain either undiagnosed or undertreated. The most common 
forms of glaucoma are age-related, generally beginning in midlife and progressing slowly 
but relentlessly as the age advances (A.T.G.S.R.S.G., 2009). If detected early enough, disease 
progression can be slowed with drug and/or surgical treatment, emphasizing the 
importance of identifying the disease in its earliest stages.  
Glaucoma is broadly classified into primary and secondary glaucoma based on their 
etiology and aqueous humor dynamics (Shields, 2005). Based on anatomy of the anterior 
chamber (gonioscopy), primary glaucomas are further classified as primary open angle 
glaucoma (POAG) and primary angle closure glaucoma (PACG). Depending on the time of 
onset, glaucoma is also termed as infantile, juvenile and adult type. Rarely glaucoma may be 
found in babies at birth this form of glaucoma called congenital glaucoma. Secondary 
glaucomas are characterized by the involvement of predisposing ocular or systemic diseases 
such as uveitis, trauma, or diabetes thereby resulting in an alteration of aqueous humor 
dynamics. Pseudoexfoliation glaucoma (XFG) and pigmentary glaucoma (PG) are the most 
frequently reported type of secondary glaucoma (Shields, 2005).   
Glaucoma affects 70 million people and is the second leading cause of blindness worldwide. 
It is estimated that by the year 2020, this number would rise to around 79.6 million (Quigley 
& Broman, 2006). The prevalence of glaucoma varies widely across the different ethnic 
groups (He et al., 2006; Wong et al., 2006; Sakata et al., 2007; Cedrone  et al., 2008; Vijaya et 
al., 2008a; 2008b; Pekmezci et al., 2009)  and is significantly higher in blacks (4.7%) as 
compared to in the white (1.3%) population  (Kwon et al., 2009). Primary open angle 
glaucoma is the predominant disease among whites and Africans (Tielsch et al., 1991; Klein 
et al., 1992; Rotchford & Johnson, 2002; Rotchford et al., 2003; Varma et al., 2004; Friedman et 
al., 2006; Sakata et al., 2007) while PACG is a major form of glaucoma in Asians (Hu et al., 
www.intechopen.com
 The Mystery of Glaucoma 
 
230 
1989; Jacob et al., 1998; Foster & Johnson, 2001; Casson et al., 2007). Epidemiological studies 
reveal that the prevalence of POAG around the world varies by about 2 orders of magnitude 
with the lowest estimates found among Eskimos (0.06%) residing in Alaska  (Arkell et al., 
1987) and the highest prevalence among African-derived people living in the Caribbean 
(7.1− 8.8%) (Mason et al., 1989; Leske et al., 1994). PACG is leading cause of the most of the 
bilateral glaucoma related blindness in Singapore, China, and India.  It has been estimated 
that PACG blinds more people than POAG worldwide (Dandona et al., 2000; Foster et al., 
2000). According to a recent study glaucoma is the major cause of blindness in Saudi Arabia. 
The prevalence of both POAG and PACG is higher in western region of Saudi Arabia as 
compared to other Asian countries (Eid et al., 2009). To date no national study has been 
undertaken to determine the exact prevalence of glaucoma in this country. 
Elevated intraocular pressure (IOP) is a major risk factor in glaucoma which is supported by 
the fact that experimentally induced elevation of IOP leads to glaucoma in animals 
(Levkovitch-Verbin et al., 2002). The  etiology of raised IOP and resulting glaucoma is not fully 
understood. Fluid formed by the ciliary body (aqueous humor) is removed by the trabecular 
outflow pathways, which includes the trabecular meshwork, the juxtacanalicular connective 
tissue, the endothelial lining of Schlemm’s canal, and the collecting channels and the aqueous 
veins (A.T.G.S.R.S.G., 2009). The IOP is dependent on the rate of fluid removal, which under 
normal conditions matches the rate of formation. In most patients with glaucoma, the rate of 
fluid removal declines so that it no longer keeps pace with the rate of formation resulting in 
the increased IOP. The increase in IOP has been associated with genetic factors, age and 
oxidative stress (Tschumper & Johnson, 1990; Leske et al., 1995; Green et al., 2007). Although 
elevation of intraocular pressure (IOP) is often related to the optic nerve damage in glaucoma, 
factors other than IOP are likely to play a role in the pathogenesis of glaucomatous optic 
neuropathy, particularly in individuals with normal tension glaucoma (NTG).  
The loss of retinal ganglion cells (RGC) is the typical pathology in glaucoma. Progressive loss 
of optic nerve axons and RGCs result in characteristic optic nerve atrophy and visual field 
defects in glaucoma patients. A number of hypotheses have been put forward that describe the 
sequence of events responsible for triggering ganglion cell degeneration in glaucoma. These 
include compromised  blood flow of the optic nerve, mechanical compression due to raised 
IOP, loss of neurotrophic factors, autoimmune mechanisms, nitric oxide-induced injuries to 
the optic nerve and glutamate excitotoxicity (Mozaffarieh et al., 2008). A combination of these 
factors may be involved in causing glaucomatous RGC loss.  Animal models also confirmed 
that acute IOP elevation causes blockage of brain-derived neurotrophic factor (BDNF) 
transport and may contribute to neuronal death (Pease et al., 2000). On the other hand the 
mechanisms involved in the pathophysiology and development of PACG are rather 
complicated and involve the anatomy of the angle, and the spatial and structural relationships 
between the lens and the anatomy of the angle, the iris, and the lens. Most mechanisms for 
PACG impute to the increasing lens thickness during aging in a relatively small eye and a 
shallow anterior chamber. Acute PACG has been attributed to morphometeric characteristics 
of the eye. Human sclera undergoes active remodeling during the development of myopia. 
Biochemical assays from highly myopic eyes show markedly reduced amounts of biochemical 
markers for collagen and glycosaminoglycans, when compared with the similar sclera of 
emmetropic eyes. This remodeling process occurs in concert with an increase in the production 
and enhanced activation of collagen degrading enzymes, particularly matrix metalloproteases 
(MMPs) (McBrien & Gentle, 2001). The net effect of these changes is a loss of scleral tissue at 
the posterior pole of the eye. 
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Growing evidence obtained from clinical and experimental studies strongly suggests the 
involvement of the immune system in glaucoma (Helpern & Grosskreutz, 2002; Wax & 
Tezel, 2002; Tezel & Wax, 2000; 2003).  Paradoxically the role of immune system in 
Glaucoma has been described as either neuroprotective or neurodestructive. A balance 
between beneficial immunity and harmful neurodegeneration may ultimately determine the 
fate of RGCs in response to various stresses in glaucomatous eye (Tezel & Wax 2007). T-cell-
mediated immune response may initially be beneficial to limit neurodegeneration (Schwartz 
& Kipnis, 2001, 2002; Kipnis et al., 2002).  However, a failure to properly control aberrant, 
stress-induced immune response likely converts the protective immunity to an autoimmune 
neurodegenerative process that can facilitate the progression of neurodegeneration in some, 
if not all, glaucoma patients (Tezel & Wax, 2007). Expansion and secondary recruitment of 
circulating T cells through an antigen mediated process is supported by the evidence of 
abnormal T-cell subsets (Yang et al., 2001a)  and increased production of serum 
autoantibodies to different optic nerve and retina antigens in many glaucoma patients (Tezel 
et al., 1998, 1999; Wax et al., 1998a, 1998b; Yang et al., 2001b) Furthermore, initial in vivo 
studies support the feasibility of eliciting an experimental autoimmune model of 
glaucomatous neurodegeneration in which RGCs progressively die in specific antigen-
immunized animals by exhibiting a pattern of neuronal damage similar to that of human 
glaucoma (Wax &Tezel, 2009). As the role of the immune system in glaucoma is one of the 
surveillance, in which signal pathways of the immune system regulate cell death in response 
to conditions that stress retinal neurons in glaucoma. Recent studies have focused on 
immunological changes occurring in glaucoma pathogenesis and possible preventive 
therapies based along those lines have been proposed. The major targets of interest are 
cytokines, as these inflammatory mediators play an important role in the pathogenesis of 
glaucoma and may regulate RGC survival or death (Tezel & Wax, 2004).  
The role of tumor necrosis factor (TNF), an important proinflammatory cytokine is a subject 
of interest in glaucoma studies. Both TNF-ǂ, produced mainly by monocytes and activated 
macrophages and TNF-β, produced mainly by activated T-cells, play important 
immunoregulatory roles in various diseases. TNF-ǂ is up regulated in several 
neurodegenerative disorders including optic nerve microglia and astrocytes in glaucoma 
(Yuan & Neufeld, 2000; 2001). It has been suggested that cell death mediated by TNF-ǂ is a 
contributing factor in the progression of neurodegeneration in glaucoma (Tezel et al., 2001). 
TNF-α plays a critical role in optic neuropathy by initiating the inflammatory pathways 
through the induction of NOS-2 in astrocytes (Yuan & Neufeld, 2000). It has been observed 
that ischemic or pressure-loaded glial cells produce TNF-α which results in 
oligodendrocytes death and the apoptosis of RGC leading to glaucomatous 
neurodegeneration (Tezel & Wax, 2000). Furthermore, TNF-α directly induces apoptosis 
through TNF-α receptor-I (TNFRI) also known as death receptor which is mainly localized 
on the retinal ganglion cells (Tezel et al., 2001). The substantial role of TNF-α/TNFRI in the 
pathogenesis of glaucoma has also been supported by experimental study on mouse model 
of glaucoma in which induction of ocular hypertension resulted in a rapid up regulation of 
TNF-α followed by loss of optic nerve oligodendrocytes (Nakazawa et al., 2006). Moreover, 
intravitreal TNF-α injection in normal mice mimicked glaucoma like RGCs degeneration 
whereas anti-TNF-α neutralizing antibody or deleting the TNF-α gene blocked the 
deleterious effects of ocular hypertension (Nakazawa et al., 2006). Tezel et al. (2004) also 
reported that unilateral optic nerve crush injury in mice resulted in significantly less glial 
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activation, TNF-α production and retinal ganglion cell death in TNFRI -knockout mice. In 
fact, histopathologic studies have also shown increased immunostaining for TNF-α and 
TNFRI in the glaucomatous optic nerve head as compared to age-matched control samples 
(Yan et al., 2000; Yuan & Neufeld, 2000). Interestingly, a new antiglaucoma drug (GLC756) 
significantly suppressed LPS-induced TNF-α production (Laengle et al., 2006a, 2006b). 
These observations further confirm the hypothesis of an involvement of the TNF-α /TNFRI 
signaling pathway in the pathogenesis of glaucoma. 
The genes for TNF-ǂ (OMIM 191160) and TNF-β also known as  lymphotoxin-ǂ (LT-ǂ, MIM 
153440), located within the MHC III region of chromosome 6, shows close linkage to the 
HLA class I (HLA-B) and class II (HLA-DR) genes. Studies on monozygotic twins and their 
first-degree relatives, using ex vivo endotoxin stimulated whole blood samples, have 
provided evidence that 60% of variation in the production capacity of TNF-ǂ appears to be 
genetically determined (Westendorp et al., 1997).  Several polymorphisms within the 
promoter region of TNF-ǂ and the intron 1 polymorphism of TNF−β, in particular, have 
been associated with altered levels of circulating TNF-ǂ (Sharma et al., 2006; 2008).   
With regard to PACG a number of lines of evidence have suggested that both genetic and 
environmental factors contribute to the development of PACG (Lowe, 1972). There are 
various published studies that suggested  a genetic basis of the PACG (Aung et al., 2008a; 
2008b). PACG, as a common complex disease, has become an important target for 
association studies in recent years. Genetic heterogeneity is illustrated by the several loci in 
many glaucoma causing genes identified to date. Single nucleotide polymorphisms in 
several genes such as matrix metalloproteases-9 (MMP-9), Cytochrome P450 1B1 (CYP1B1), 
membrane-type frizzled-related protein (MFRP) , methylenetetrahydrofolate reductase gene 
(MTHFR), myocilin (MYOC), calcitonin receptor-like gene (CALRL), endothelial nitric oxide 
synthase (eNOS), heat shock protein 70 (HSP70), retinal homeobox gene (CHX10), have been 
associated with PACG (Wang et al., 2006; Chakrabarti et al.,  2007;  Michael et al., 2008; 2009, 
Aung et al., 2008; Dai et al., 2008; Cong et al., 2009; Cao et al., 2009, Ayub et al., 2010). 
However, ethnic variations exist in the association between these polymorphisms and 
PACG, and many cases such association has not been replicated in subsequent research 
(Wang et al., 2006; Aung et al., 2008a). Moreover, the biological significance of the some 
associated single nucleotide polymorphisms (SNPs) in the development of PACG is still 
unknown (Michael et al., 2008). PACG has been reported to be associated with genes related 
to regulation of axial length and structural remodeling of connective tissues, such as  MFRP, 
MMP-9, and  MTHFR genes (Michael et al., 2008; Wang et al., 2006; Aung et al., 2008a; 2008 
b; Wang et al., 2008). It has also been reported  that TNF-ǂ is capable of inducing both 
increased synthesis and activity of matrix metalloproteinases (MMPs) (Rajavashisth et al., 
1999; Siwik et al., 2000; Uchida et al., 2000) therefore  the polymorphism in TNF  genes 
might be associated with regulation of axial length and structural remodeling of connective 
tissues and ultimately  to the development of PACG. 
Several polymorphisms have been reported in the promoter region of TNF-α gene. One of 
the best described single nucleotide polymorphisms (SNPs) is located at nucleotide position 
-308 within the TNF-α promoter region (rs1800629) and affects a consensus sequence for a 
binding site of transcription factor AP-2 (Abraham & Kroeger, 1999). TNF-α promoter 
polymorphism leads to a less common allele-A (allele 2) which has been associated with 
increased TNF-α production in vitro (Braun et al., 1996; Wilson et al., 1994) and higher rate of 
TNF-α transcription  than wild type GG genotype (Wilson et al., 1997; Jeong et al., 2004). This 
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polymorphism has been linked to increased susceptibility to several chronic metabolic 
degenerative, inflammatory and autoimmune diseases (Cuenca et al., 2001). It has also been 
reported to be involved in increased susceptibility to different eye diseases including diabetic 
retinopathy and glaucoma (Limb et al., 1999; Yoshioka et al., 2006; Huang et al., 2009). TNF-
α ιs involved in T-cell dependent B-cell responses, T-cell proliferation, natural killer (NK)-cell 
activity and dendritic cell maturation. The previously published data indicate that the host’s 
ability to produce TNF-α may play an important role in vulnerability to glaucoma.  
Of interest, G/A polymorphism at nucleotide position –308 within the human TNF-α 
promoter region is associated with elevated TNF levels, disease susceptibility, and poor 
prognosis in several diseases (Messer et al., 1991; Wilson et al., 1992; Galbraith & Pendey, 
1995; Patino-Garcia et al., 2000). Adenine at position –308 makes the TNF-α promoter a 
much more powerful transcription activator than guanine (Messer et al., 1991). The TNF-ǂ  
is up regulated in several neurodegenerative disorders including multiple sclerosis, 
Parkinson’s disease, Alzheimer’s disease (Shohami et al., 1999; Yan et al., 2000; Liu et al., 
2006) and in optic nerve microglia and astrocytes in glaucoma patients (Yuan & Neufeld, 
2000; 2001]. Increased TNF-ǂ level have been associated with a poor prognosis after trauma 
in the brain (Munoz-Fernandez & Fresno, 1998; Ertel et al., 1995), whereas a decrease in 
TNF-ǂ is known to reduce nerve damage. In a rat cerebral ischemic model, exogenous TNF-
ǂ was found to exacerbate focal ischemic injuries, whereas blocking endogenous TNF-ǂ was 
neuroprotective (Shohami et al., 1996). 
TNF-β resembles to TNF-ǂ in terms of several biological activities including apoptosis and 
gives rise to a similar pro-inflammatory response and has been shown to play a critical role 
in pathogenesis of many diseases. TNF-β gene polymorphism at nucleotide position 252 
within first intron (A252G) (rs909253) affects a phorbol ester-responsive element. The 
presence of G at this position defines the mutant allele known as TNF-β ∗ 1 (allele-1) which 
is less frequent allele in white subjects and is associated with higher TNF-α and TNF-
β production (Messer et al., 1991; Abraham et al., 1993). Association of TNF-β +252 A/G 
polymorphism has  been reported with various  autoimmune disorders  including  Gravis’ 
disease (Kula et al., 2001)  idiopathic membranous glomerulonephritis, IgA nephropathy, 
insulin dependent diabetes mellitus (Medcraft et al., 1993) , myasthenia gravis (Zelano et al., 
1998), asthma diathesis (Albuquerque et al., 1998), SLE with nephritis(Lu et al., 2005), 
systemic sclerosis (Pandey &Takeuchi, 1999), plaque psoriasis (Vasku et al., 2000), 
rheumatoid arthritis  (Takeuchi et al., 2005), myocardial infarction in patients with 
rheumatoid arthritis (Panoulas et al., 2008), and type 1 diabetes (Boraska et al., 2009). 
Recently TNF-β +252 A/G polymorphism is reported to be associated with both 
susceptibility to and mortality from sepsis (Watanabe et al., 2010; Tiancha et al., 2011).  
A few studies have been undertaken to determine the association of TNF-α polymorphisms 
and glaucoma in different part of the world (Limb et al., 1999; Yoshioka et al., 2006; Huang 
et al., 2009). The results of these studies on association of TNF-ǂ polymorphism with POAG 
are inconsistent. These differences in findings have been attributed to variation in sample 
size, ethnicity and method of diagnosis (Lin et al., 2003; Mossbock et al., 2006; Tekeli et al., 
2008; Razeghinejad et al., 2009). To date there is no report available on the association 
between TNF-β   polymorphism and glaucoma. The joint analysis of polymorphism at TNF-
α  and TNF-β  given that both are involved in the expression of TNF-α and in a suggested 
mechanism for autoimmune diseases, will  provide further insight into the pathogenesis of 
glaucoma and help in developing effective therapeutic agents. Therefore the present study 
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was undertaken to determine the possible association of TNF-α-308 and TNF-β +252 gene 
polymorphisms with POAG and PACG in Saudi population. 
2. Methods 
2.1 Subjects 
The present study was undertaken to evaluate the association of TNF-α and TNF-β alleles 
and genotypes in Saudi primary glaucoma patients. A total of 200 unrelated Saudi patients 
with Primary Glaucoma [primary open angle glaucoma (POAG) and primary angle closure 
glaucoma (PACG)] were recruited from ophthalmology clinic of the Riyadh Military 
Hospital (RMH), Saudi Arabia. The patient group consisted of 94 males and 106 females, 
with age at diagnosis ranging from 25 to 78 years (mean ± SD: 58 ± 14.4). The control group 
consisted of 200 unrelated   subjects, 100 males and  100 females, ages ranging from 25 to 68 
years (mean ± SD: 55 ± 11.6). The diagnosis of primary glaucoma was based on   
comprehensive clinical examination as mentioned below.   
2.2 Preliminary examination 
The preliminary examination was performed in ophthalmology clinic of RMH. Detailed 
demographic data and medical history were recorded for each case and control subject. The 
preliminary examination included oblique flashlight test, anterior segment evaluation by slit 
lamp, Goldmann applanation tonometry, and direct fundoscopy (all examinations 
performed by resident/consultant ophthalmologists). The optic disc was examined after 
each pupil was dilated with 2 drops of tropicamide, unless contraindicated by the presence 
of a shallow anterior chamber depth at the slit lamp examination. The vertical cup-disc ratio 
(VCDR) was estimated for each eye. The rim border was determined based on the course of 
the blood vessels and the gradation of color, shadows, and texture (Spaeth, 1993). A suspect 
appearance of the optic disc (glaucomatous-appearing optic disc; GAOD) was defined in 
eyes with VCDR ≥ 0.6, asymmetry of the VCDR between the two eyes ≥ 0.2, focal thinning of 
the neuroretinal rim, localized or diffuse retinal nerve fiber layer defect, and/or optic disc 
hemorrhage. A glaucoma specialist confirmed the presence of a GAOD in the participants. 
Fundus photography, automated perimetry, and gonioscopy were not part of the 
preliminary examination protocol. 
2.3 Detailed examination 
Patients with GAOD status and/or intraocular pressure (IOP) measurements > 21 mm Hg at 
the screening underwent a definitive examination. At first each subject underwent a 
comprehensive ophthalmic examination, including review of medical history, best corrected 
visual acuity(BCVA) (using Snellen distance vision chart), retinoscopy and subjective 
refraction (when visual acuity < 20/30), slit lamp biomicroscopy, IOP measurement (using 
Goldmann applanation tonometry), standard automated perimetry tests, gonioscopy (using 
Sussman four-mirror lens), and fundoscopy examination. Gonioscopy was performed by a 
consultant (glaucoma specialist). Indentation gonioscopy with four-mirror Posner lens was 
performed in eyes with an anatomically narrow angle. The angle was graded according to 
the Scheie scheme (Scheie, 1957) and the peripheral iris contour, degree of pigmentation, 
presence of peripheral anterior synechiae, and other angle abnormalities were recorded. 
When the gonioscopy showed no contraindications, dilated direct fundoscopy and slit lamp 
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biomicroscopy of the optic disc (using a 78-D lens) were performed. The VCDR was 
determined independently in a masked fashion by two glaucoma specialists and cases of 
disagreement were resolved by consensus between the two graders during the definite 
examination visit. There was a good agreement between the two graders in determining 
VCDR (0.7 or more). The presence of any notching, optic disc hemorrhages, or nerve fiber 
layer defects was documented. Initially, most of the standard automated perimetry tests 
were performed with the Octopus 101 perimeter (Haag-Strreit Octopus, Switzerland). In an 
attempt to avoid the influence of learning effect in visual field (VF) results, these VF 
examinations were not considered for assessing visual function status.  
The patients were further subjected to a second VF examination using a Humphrey visual 
field perimeter (Humphrey Visual Field Analyzer; Carl Zeiss Meditec, Inc., Dublin, CA), 
with the 24-2 full-threshold or SITA (Swedish interactive threshold algorithm) standard 
strategy. The visual function status was determined based on this single VF test, and only 
reliable VF examinations were considered for analysis. An abnormal VF examination was 
determined by the presence of one of the following criteria: (1) glaucoma hemifield test 
(GHT) result outside normal limits and (2) the presence of a cluster of ≥ 3 contiguous points 
in the pattern deviation (PD) probability plot with P < 5% or worse (within the same 
hemifield) (Foster et al., 2002). A reliable visual field test was defined as an examination 
with less than 33% of fixation losses, false positive and false negative. The glaucoma 
specialist verified whether the VF defects were consistent with glaucoma. 
2.4 Criteria for glaucoma diagnosis 
Glaucoma was diagnosed according to the International Society of Geographical and 
Epidemiologic Ophthalmology (ISGEO) classification, which uses three levels of evidence 
(Foster et al 2002). Briefly, in category 1, diagnosis was based on structural and functional 
evidence. It required CDR or CDR asymmetry ≥ 97.5th percentile for the normal population 
or a neuroretinal rim width reduced to ≥ 0.1 CDR (between 11- and 1-o’clock or 5- and 7-
o’clock) with a definite VF defect consistent with glaucoma using the Swedish interactive 
threshold algorithm 30-2. Category 2 was based on advanced structural damage with 
unproved field loss. This included those subjects in whom VFs could not be determined or 
were unreliable, with CDR or CDR asymmetry ≥ 99.5th percentile for the normal 
population. Lastly, category 3 consisted of persons with an IOP ≥ 99.5th percentile for the 
normal population, whose optic discs could not be examined because of media opacities.  
2.5 Glaucoma classification 
Participants who fulfilled any of the three categories of evidence mentioned earlier were 
classified as having POAG or PACG    
POAG: Anterior chamber angles open and appearing normal by gonioscopy, typical 
features of glaucomatous optic disc as defined earlier, and visual field defects corresponding 
to the optic disc changes. 
PACG: At least two of the criteria mentioned: glaucomatous optic disc damage or 
glaucomatous visual field defects in combination with anterior chamber angle partly or 
totally closed, appositional angle closure or synechiae in angle, absence of signs of 
secondary angle closure (e.g., uveitis, lens related glaucoma, microspherophakia, evidence 
of neovascularization in the angle and associated retinal ischemia or congenital angle 
anomalies). Patients with signs of intracranial disease that would cause optic nerve atrophy 
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in x-ray, computerized tomography or magnetic resonance imaging were excluded. An 
anatomically narrow-angle eye should have pigmented trabecular meshwork not visible in ≥ 
270° of the iridocorneal angle (as assessed by nonindentation gonioscopy) and/or the 
presence of peripheral anterior synechiae not explained by other causes but a primary angle-
closure process. 
2.6 Sample collection 
Venous blood was collected from the patients (POAG, PACG) and controls and stored at  
- 20°C before extraction of DNA. The study protocol was approved by the Ethics Committee 
of the Hospital. 
2.7 Genotyping 
2.7.1 PCR amplification 
Genomic DNA was extracted from the peripheral blood of   patients and controls using 
QIAampR DNA mini kit (Qiagen CA, USA). TNF-α and TNF-β genes were amplified using 
amplification refractory mutation systems (ARMS)-PCR methodology (Perry et al., 1999) to 
detect any polymorphism involved at position -308 of TNF-α and +252 in Interon1 of   TNF-
β gene respectively.  The set of primers used to amplify target DNA in the promoter region 
of TNF-α and TNF-β genes are summarized in Table 1. 
 
Locus Generic (antisense) primer Sense primers 
TNF-α  
 (G308A) 
5′-TCT CGG TTT CTT CTC CAT CG-3′ 
 
5′-ATA GGT TTT GAG GGG CAT GG-3′ 
5′-AAT AGG TTT TGA GGG GCA TGA-3′ 
TNF-β 
 (A252G)    
5′-AGA TCG ACA GAG AAG GGG ACA-3′
 
5′-CAT TCT CTG TTT CTG CCA TGG-3′ 
5′-CAT TCT CTG TTT CTG CCA TGA-3′        
Table 1. Showing sets of primers used to amplify the TNF-α  and TNF-β to detect  polymorphism  
PCR amplification was carried out using Ready to Go PCR Beads (Amersham Biosciences, 
USA). Reaction consisted of 10 temperature cycles of denaturation for 15 s at 94 °C, 
annealing for 50 s at 65 °C and extension   for 40 s at 72 °C. Then 25 cycles of denaturation 
for 20s at 94 °C, annealing for 50 s at 59 °C, extension for 50s at 72 °C. Final extension was 
performed at 72 °C for 7 m.  A positive control was included in the PCR assay by 
amplification of the human growth hormone (HGH) gene. The amplified product for 
various samples were separated on the 1.5 % agarose gel, stained with ethidium bromide 
and photographed.  
2.7.2 Statistical analysis 
The differences in allele/ genotype frequencies between patients and controls were 
analyzed by the Fisher’s exact test. P values less than 0.05 were considered significant. The 
strength of the association of disease with respect to a particular allele/genotype is 
expressed by odd ratio interpreted as relative risk (RR) following the Woolf’s method as out 
lined by Schallreuter et al. (1993). It is calculated only for those Alleles/ genotypes which 
are increased or decreased in patients as compared to control group. The RR in this study 
has been calculated for all the subjects. 
RR= (a) x (d) / (b) x (c)   where, 
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(a) = number of patients with expression of allele or genotype 
(b) = number of patients without expression of allele or genotype 
(c) = number of controls with expression of allele or genotype 
(d) = number of  controls without expression of allele or genotype 
Etiologic Fraction (EF):  The EF indicates the hypothetical genetic component of the disease. 
The values between 0 and 1 are of significance. EF is calculated for positive association only 
where RR> 1 (Savejgaard et al., 1983). 
EF= (RR-1) f / RR, where f= a/a+c 
Preventive Fraction (PF): The PF indicates the hypothetical protective effect of one specific 
allele/ genotype for the disease. PF is calculated for negative association only where RR< 1 
(Savejgaard et al., 1983). Values < 1.0 indicate the protective effect of the allele/genotype 
against the manifestation of disease.  
PF= (1-RR) f / RR (1-f) +f, where f= a/a+c 
3. Results 
In this case control study TNF-α and TNF-β genes were amplified to determine the allele 
and genotype frequencies in equal number of patients (200) and unrelated matched controls 
(200). The patient group consisted of POAG (135) and PACG (65) cases. The molecular 
analysis of the blood specimen of the patients and controls was performed in the same 
laboratory and at the same time. The investigator was blind to the phenotype of the subjects 
at the time of molecular analysis. Later on the results were separated for patient and control 
groups and analyzed for the determination of the  frequencies of genotypes and alleles.  
Allelic frequencies and genotype distributions of both TNF-α and TNF-β gene 
polymorphisms differ between primary glaucoma   (including both POAG and PACG cases) 
and control subjects (Tables 2-9).  
The results of the genotypes and alleles distribution of TNF-α  (-308) polymorphism in 
primary glaucoma (including total POAG and PACG cases) are summarized in Table 2. The 
frequency of GA (-308) genotype was significantly higher (P=0.02) while the frequency of 
GG (-308) genotype was lower in total primary glaucoma patients as compared to controls 
(P=0.01). 
 
Genotype/ Allele 
Glaucoma (N=200) Control (N=200) P- 
value 
RR EF*/PF 
N % N % 
GG 85 42.5 110 55 0.01‡ 0.60 0.23 
GA 100 50.0 76 38 0.02‡ 1.63 0.22* 
AA 15 7.5 14 7 0.85 1.08 0.04* 
G-allele (TNF-α 1-allele) 270 67.5 296 74 0.04‡ 0.73 0.15 
A-allele (TNF-α 2-allele) 130 32.5 104 26 0.04‡ 1.37 0.15* 
N, number of subjects; RR, relative risk; EF, etiological fraction; PF, preventive fraction;  
‡, statistically significant 
Table 2. Genotype and allele frequencies of (G-308A) TNF-α  variants in primary glaucoma  
patients and matched controls 
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No significant difference was noticed in distribution of AA genotype among the patients 
and controls (P=0.85). Frequency of allele A was found to be significantly increased in 
glaucoma patient while that of allele G was higher in control group (P=0.04).The higher 
frequencies of genotype GA and allele A in primary glaucoma patients as compared to 
controls indicated that the genotype GA and allele A are susceptible to the primary 
glaucoma (RR=1.63, EF=0.22 and RR=1.37, EF=0.15 respectively). The genotype GG and 
allele G being higher in controls indicating their protective nature for primary glaucoma 
(RR=0.60, PF=0.23 and RR=0.73, PF=0.15 respectively).  
The results of TNF-α -308 polymorphism for total primary glaucoma cases were then 
stratified into POAG and PACG groups. The distribution of alleles and genotypes of   TNF-
α  (-308) polymorphism in POAG are shown in Table 3. 
 
Genotype/ Allele 
Open Angle 
Glaucoma (N=135) 
Control (N =200)
P-value RR EF*/PF 
N % N % 
GG 59 43.7 110 55 0.04‡ 0.64 0.16 
GA 68 50.4 76 38 0.03‡ 1.66 019* 
AA 8 5.9 14 7 0.82 0.84 0.06 
G-allele (TNFα  1- allele) 186 68.9 296 74 0.16 0.83 0.07 
A-allele (TNFα  2 -allele) 84 31.1 104 26 0.16 1.21 0.07* 
N, number of subjects; RR, relative risk; EF, etiological fraction; PF, preventive fraction; ‡, statistically 
significant 
Table 3. Genotype and allele frequencies of (G-308A) TNF-α variants in open angle 
glaucoma patients and controls 
The frequency of genotype GA was significantly higher in POAG patients (P=0.03) while the 
frequency of GG was lower in POAG as compared to controls (P=0.04). The frequency of 
allele  A was higher whereas the frequency of allele  G  was lower in PAOG patients as 
compared to control. However,  the differences were not statistically significant for both 
alleles (P=0.16).  The higher frequency of GA genotype in POAG indicated that the genotype 
GA of TNF-α -308  polymorphism might be susceptible to POAG (RR=1.66, EF=0.19) while 
the increased frequency of genotype GG in controls as compared to POAG patients 
indicated that genotype GG is resistant  to POAG (RR=0.64,PF=0.16). 
The frequencies of alleles and genotypes of   TNF-α  (-308) polymorphism in PACG is given 
in Table 4. The frequency of genotype GG was significantly lower in PACG as compared to 
controls (P=0.04). Although the frequency of genotype GA and AA was   higher in PACG, 
the difference was not statistically significant (P=0.11 and P=0.42 respectively). The 
frequency of allele A was significantly increased in PACG as compared to controls (0.04) 
indicating that the allele A might be susceptible to the PACG (RR=1.56, EP= 0.11) while 
allele G might be protective (RR=0.64, PF=0.11) in Saudi patients with PACG. Similarly the 
lower frequency of genotype GG in PACG as compared to controls indicated that GG is 
protective for PACG (RR=0.55, PF=0.14). 
Comparison of the distribution frequency of genotypes and alleles of TNF-α  (-308) 
polymorphism between the POAG and PACG type of glaucoma is summarized in Table 5. 
The results of the genotype and allele distribution in the two types of glaucoma (POAG and 
PACG) show similar pattern without insignificant differences. 
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Genotype/ Allele 
Angle closure 
glaucoma (N=65) 
Control 
(N=200 ) 
P- 
value 
RR EF*/PF 
N % N %    
GG 26 40 110 55 0.04‡ 0.55 0.14 
GA 32 49.2 76 38 0.11 1.58 0.11* 
AA 7 10.8 14 7 0.42 1.60 0.12* 
G-allele  (TNFα 1-allele) 84 64.6 296 74 0.04‡ 0.64 0.11 
A-allele (TNFα 2-allele) 46 35.4 104 26 0.04‡ 1.56 0.11* 
N, number of subjects; RR, relative risk; EF, etiological fraction; PF, preventive fraction;  
‡, statistically significant 
Table 4. Genotype and allele frequencies of (G-308A) TNF-α  variants in angle closure 
glaucoma patients and controls 
 
Genotype/Allele 
Open angle glaucoma  
(135) N  ( %  ) 
Angle closure glaucoma (65) 
N   (%) 
P-value 
GG 59 (43.7) 26  (40) 0.76 
GA 68 (50.4) 32 (49.2) 0.88 
AA 8  (5.9) 4 (10.8) 0.25 
G-allele (TNFα 1-allele 186 (68.9) 84 (64.6) 0.42 
A-allele (TNFα 2-allele) 84  (31.1) 46 (35.4) 0.42 
Table 5. Comparison of genotype/ allele frequencies of TNF-α (G308A) polymorphism 
between POAG and PACG 
Our studies  on TNF-β  gene polymorphism at position +252 of intron1 showed that  the 
frequency of GG was significantly higher  in  primary glaucoma (including total POAG and 
PACG cases) as compared to controls (P=0.001) while the frequency of GA genotype was 
significantly lower  in glaucoma patients (P=0.001). Allele-G was predominantly distributed 
in glaucoma patients (P=0.001) whereas frequency of allele A was significantly higher in 
control group (P= 0.011). Though there was difference in the distribution of AA genotype 
among the primary glaucoma and control, the difference was not statistically significant 
(P=0.25) (Table 6). 
 
Genotype/Allele 
Glaucoma 
(N=200) 
Control (N=200)
P-value RR EF*/PF 
N % N % 
GG 69 34.50 28 14 0.001‡ 3.235 0.491* 
GA 99 49.50 148 74 0.001‡ 0.344 0.432 
AA 32 16.00 24 12 0.253 1.396 0.161* 
G-allele (TNFβ 1-allele) 237 59.25 204 51 0.011‡ 1.396 0.152* 
A-allele (TNFβ 2-allele) 163 40.75 196 49 0.011‡ 0.715 0.152 
N, number of subjects; RR, relative risk; EF, etiological fraction; PF, preventive fraction;  
‡,  statistically significant 
Table 6. Genotype and allele frequencies of TNF-β (LTα)- interon1 +252 variants in  primary 
glaucoma patients and matched controls 
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The increased frequencies of genotype GG and allele G of TNF-β  (LTα) - interon1 +252 
polymorphism   in patients group indicated that genotype GG/allele G is susceptible to the 
primary glaucoma (RR=3.235, EF=0.491and RR=1.396, EF=0.152 respectively) whereas the 
decreased frequencies of the genotype GA and allele A in glaucoma patients showed their 
resistant/ refractory nature (RR=0.344, PF=0.432 and RR=0.715, PF=0.52 respectively). 
On stratification of results for two types of glaucoma (POAG and PACG), the distribution of 
genotypes and allele of TNF-β (LTα) - interon1 +252 polymorphism retained almost the 
same pattern in POAG and PACG  as was in the results for the total primary glaucoma 
group (Tables 7, 8). The frequency of genotype GG and allele G were higher in   POAG as 
compared to controls (P=0.001 and P=0.05 respectively) while the frequencies of genotype 
GA and allele A were higher in controls (P=0.001 and P=0.05 respectively).  
The increased frequencies of genotype GG (RR=3.28, EF=0.435) and allele G (RR=1.376, 
EF=0.119) in POAG as compared to controls (Table 7) indicated that genotype GG and allele 
G are susceptible to the POAG in Saudis. The reduced frequencies of genotype GA 
(RR=0.326, PF= 0.386) and allele A (RR=  0.726, PF=0.119) in the POAG patients as compared 
to controls showed that genotype GA and allele A of TNF-β intron1+252 polymorphism are 
resistant for POAG. 
  
 
Genotype/ Allele 
Open angle 
glaucoma (N=135)
Control (N=200)
P-value RR EF*/PF 
NO. % NO. % 
GG 47 34.81 28 14 0.001‡ 3.280 0.435* 
GA 65 48.15 148 74 0.001‡ 0.326 0.386 
AA 23 17.04 24 12 0.20 1.506 0.164* 
G-allele (TNFβ 1-allele) 159 58.89 204 51 0.05‡ 1.376 0.119* 
A-allele (TNFβ  2-allele) 111 41.11 196 49 0.05‡ 0.726 0.119 
N, number of subjects; RR, Relative risk; EF, etiological fraction; PF, preventive fraction;  
‡, statistically significant  
Table 7. Genotype and allele frequencies of TNF-β (LTα) - interon1+252 variants in  Open 
angle glaucoma patients and matched controls    
The distribution of genotypes and alleles of TNF-β intron1+252 polymorphism is shown in 
Table 8. The frequency of genotype GG was higher in PACG as compared to controls 
(P=0.001) while the frequencies of genotype GA was higher in controls (P=0.001). The higher 
frequencies of genotype GG  in PACG as compared to controls indicated that genotype GG 
is susceptible  to the disease (RR=3.142, EF=0.299) while genotype  GA might be refractory 
for PACG as the frequency of GA was higher in controls RR=0.385, PF=0.229). The 
frequency of  allele G was also higher in PACG and  that of allele A was lower in PACG as 
compared  to controls however, the difference in the frequency distribution of allele A and 
G was not significant in PACG (P=0.08). 
Comparison of the distribution frequency of genotypes and alleles of TNF- β  (LT-α) interon 
1+252 polymorphism between the POAG and PACG is summarized in Table 9. The results 
clearly indicated that the genotype and allele distribution in the two types of glaucoma 
(POAG and PACG) have similar pattern with minor insignificant differences. 
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Genotype/Allele 
Angle closure 
glaucoma (N=65) 
Control 
(N=200) P-value RR EF*/PF 
NO. % NO. % 
GG 22 33.85 28 14 0.001‡ 3.142 0.299* 
GA 34 52.30 148 74 0.001‡ 0.385 0.229 
AA 9 13.85 24 12 0.67 1.078 0.041* 
G-allele (TNFβ 1-allele) 78 60.00 204 51 0.08 1.441 0.084* 
A-allele (TNFβ 2-allele ) 52 40.00 196 49 0.08 0.693 0.084 
N, number of subjects; RR, Relative risk; EF, etiological fraction; PF, preventive fraction;  
‡,  statistically significant  
Table 8. Genotype and allele frequencies of TNF- β (LT-α)  interon1+252 variants in angle 
closure glaucoma patients and matched controls  
  
Genotype/Allele 
Open angle  
glaucoma  (135) 
N    ( %  ) 
Angle closure  
glaucoma  (65) 
N    (%) 
P-value 
GG 47   (34.81) 22  (33.85) 1.00 
GA 65   (48.15) 34  (52.30) 0.65 
AA 23  (17.04) 9  (13.85) 0.68 
G-allele (TNFβ 1-allele) 159  (58.89) 78  (60.00) 0.45 
A-allele (TNFβ 2-allele) 111  (41.11) 52  (40.00) 0.45 
Table 9. Comparison  of genotype/ allele frequencies of TNF- β (G252 A) polymorphism  in 
POAG and PACG 
The comparison between the associations of TNF-α 308 polymorphism in glaucoma patients 
in various ethnic populations is given in Table 10. The distribution trend shows ethnic 
variations. TNF -α (-308) polymorphism is strongly associated with POAG in Saudis, 
Chinese and Iranian but not in Caucasians and Japanese.  
4. Discussion  
As early as 1873, Dooremal for the first time observed that the eye is one of the immune 
privileged region of the body which was later described by Streilein (1999). Multiple factors 
have been suggested to contribute to the immune privilege of the eye (Niederkorn, 2006) 
such as the blood- aqueous- barrier and the fact that eyes do not have a lymph drainage 
system. Aqueous humor is for example, capable of suppressing cytokine production by 
activated T-lymphcytes (Mochizuki et al., 2000). 
The anterior chamber of the eye has an active immunomodulation (Streilein, 2003). It has 
also been suggested that autoimmune damage to the optic nerve may occur directly by 
autoantibodies or indirectly by a “mimicked” autoimmune response to a sensitizing antigen, 
which in turn injures retinal ganglion cells (Wax, 2000). In a   study by Joachim et al. (2007) 
IgG antibody levels were found to be significantly higher in the aqueous humor of patients 
with POAG and PEXG as compared to controls, suggesting the role of multiple immune 
factors in glaucoma.  
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Study Ethnicity
No. of 
Patients
Glaucoma TNF –α (308) polymorphism 
Present study Saudis 200 
Primary 
glaucoma 
(POAG 
+PACG) 
Associated with TNF –α-308 GA 
Lin et al.,  2003 Chinese 60 POAG Associated with TNF –α-308 AA 
Fan et al.,  2010 Chinese 405 POAG Associated with TNF –α-308G 
Razeghinejad et al., 
2009 
Iranian 223 POAG Associated with TNF –α-308A 
Funayama et al., 2004 Japanese 194 POAG No association 
Mossbock et al.,  2006
Caucasia
n 
114 POAG No association 
Table 10. Association of TNF-α  308 polymorphism in glaucoma patients in  various ethnic 
populations 
Growing evidence obtained from clinical and experimental studies over the past decade 
strongly suggests the role of immune system in the pathogenesis of various types of 
glaucoma. It has been observed that immune mediators are not usually the primary 
causative agents but play a critical role in the progression of the disease (Funayama et al., 
2004; Joachim et al., 2007). In addition, it has been reported that components of the immune 
system involved in the pathogenesis of glaucoma are also involved in neurodegeneration 
following brain injury. In such cases inflammation occurs in response to glutamate, reactive 
oxygen species (ROS), nitric oxide (NO), and cytokines including tumor necrosis factor-ǂ 
(TNF-ǂ), which are released from activated microglia or macrophages (Schwartz, 2007). As 
glaucoma is a disease of old age and involves optic nerve neuropathy, it has been proposed 
that both genetic as well as epigenetic factors are involved in the progression of the disease. 
Such factors cause a decrease in the cellular viability and self renewal capacity, which 
results in the generation of dysfunctional microglia. Such age-related attrition may 
contribute to the development of neurodegenerative diseases by diminishing glial 
neurosupportive functions. Secondary degeneration by the immune components leads to 
the neurodegenerative injury in glaucoma (Levkovitch-Verbin et al., 2003).  
TNF-ǂ is considered to be a neuroprotective component of the immune system, because it 
activates the ubiquitous transcription factor NF-κB through binding to the high affinity TNF 
receptors (TNF-R2), which in turn mediates the expression of a wide range of genes essential 
for neuronal survival. Contrary to its neuroprotective role, TNF-ǂ can also serve as a 
neurodegenerative factor when it binds to the low affinity death receptors TNF-R1 and 
activates the mitochondria mediated apoptotic pathway (Lilienbaum & Israel, 2003; 
Marchetti et al., 2004, Tezel & Yang, 2005). Thus a delicate balance between the two 
pathways determines the survival of the cell, and any shift in equilibrium might have 
deleterious effects. An increased expression of TNF-ǂ can shift the balance toward TNF-R1 
signaling, as seen in glaucoma, and thus promote retinal ganglion cell death.  
In the present study we found a strong association of GA genotype of TNF-α  (-308) 
polymorphism with primary glaucoma, suggesting its role in the pathogenesis of the 
glaucoma. The results of our study showing the association between TNF-α-308 
polymorphism and glaucoma are in agreement with some of the published data on Asian 
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populations. A recent study from Iran showed that inheritance of high producer TNF -α-308 
A allele is susceptibility factor for development of POAG (Razeghinejad et al., 2009). A 
highly significant association of POAG and TNF -α-308 AA genotype has also been 
observed   in the Chinese population (Lin et al., 2003). These investigators suggested that the 
close association between TNF-α 308 A/AA and POAG could be used as genetic marker for 
the disease mapping and identifying subjects susceptible to glaucoma.  On the other hand in 
another study from China the frequency of allele G of TNF-ǂ 308 was higher in patient 
group than controls and it was suggested that variants in TNF were risk factors for POAG in 
the Chinese population (Fan et al., 2010).  The variations in association of TNF-ǂ(-308) 
polymorphism with POAG (Table 10) could be due to racial differences, sample size, poorly 
characterized controls and clinical heterogeneity between different samples. Khan et al. 
(2009) found a close association between TNF-α 308 polymorphism and pseudoexfoliation 
glaucoma (PEXG, a type of secondary glaucoma) in Pakistani population. These findings 
clearly suggest that transcriptional regulation of TNF-α is essential to circumvent the 
deleterious effects of over expression by transcriptional up regulation. The results of this 
study clearly suggest that excessive production of TNF-α associated with the G-308A 
polymorphism may have an important role in the development of glaucoma and may act as 
a genetic susceptibility factor driven by a high TNF-α expression, which would 
subsequently lead to immune responses causing the onset and /or progression of the 
disease. This hypothesis is further supported by the findings of several earlier investigators 
showing upregulation of the expression of TNF-α and TNF-α receptor-1 in the retina and 
optic nerve head in glaucomatous eyes (Yan et al., 2000; Tezel et al., 2001; Yuan & Neufeld, 
2000). Agarwal et al. (2000) reported that the G to A transition at position −308 results in a 
six- to sevenfold increase in transcription of TNF-α as compared to normal basal level. 
Similarly Abraham & Kroeger (1999) demonstrated the functionality of TNF-α-308 
polymorphism in the reporter gene assays with a significant up regulation of up to five fold 
in the constructs of TNF1 (G-allele) and TNF2 (A-allele). A recent study by Sawada et al. 
(2010) demonstrated that TNF-ǂ levels were significantly elevated in the aqueous humor of 
glaucoma patients as compared to controls.  
Contrary to our findings on Saudi population, studies on Japanese and Austrian Caucasian 
populations showed no association between TNF-ǂ polymorphism G-308A and primary 
glaucoma (Funayama et al., 2004; Mossbock et al., 2009). These differences may be attributed to 
the variation in ethnicity, sample size, poorly characterized controls and clinical heterogeneity 
of the patients.  However, Funayama et al. (2004) noticed a definite interaction between 
polymorphism in Optineurin (OPTN) and TNF-α genes that would increase the risk for 
glaucoma in Japanese which indirectly suggest the participation of immune mechanism in 
glaucoma. The variation in Japanese population to some extent may be attributed to the fact 
that G-308 A polymorphism is very rare in this population (Allen, 1999). 
The role of immune system in glaucoma is further substantiated by the fact that TNF-α 
mediated activation of matrix metalloproteinases (MMPs) in aqueous humor of the eye 
results into optic neuropathies. Several in vitro studies have  shown that TNF-ǂ is capable of 
inducing both increased synthesis and activity of MMPs  (Rajavashisth et al., 1999; Siwik et 
al., 2000; Uchida et al., 2000). The MMPs are a family of zinc-dependent endopeptidases that 
have been reported to cause the degradation of the extracellular matrix (ECM) 
(Stamenkovic, 2003) and involved in wide range of normal and pathological conditions. 
Uncontrolled activation of MMPs is counterbalanced by specific tissue inhibitors of 
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metalloproteinases (TIMPs), and a delicate balance of MMPs and TIMPs is required for 
physiologic ECM turnover. An impaired balance between MMPs and TIMPs may thus 
contribute to the development of glaucoma (Schlötzer-Schrehardt et al., 2003; Määttä et al., 
2005). The higher frequency of  Allele-A in our patients  clearly suggest   increased  secretion 
of  TNF-ǂ  which  lead to  increased synthesis and activity of  MMPs. Increased expression 
of MMPs has been associated with structural remodeling of connective tissues of eye  which 
might lead to the development of PACG (Papp et al., 2006). Further studies are warranted to 
confirm the role of MMPs in TNF-α mediated genesis of glaucoma and other eye diseases. 
In our study the GG genotypes of TNF-β (+252) polymorphism were significantly over-
represented in glaucoma patients as compared to the controls (P= 0.001) while GA genotype 
was significantly higher in controls as compared to glaucoma patients (P=0.001) indicating 
that GG,   genotypes at +252 were susceptible to glaucoma (RR=3.235, EF=0.491), whereas 
GA was found to be refractory (RR=0.344, PF=0.432). Similarly the higher frequency of 
allele-G of TNF-β (+252) polymorphisms in patients (P=0.011) indicated that Allele G is 
associated with glaucoma. TNF-β (+252) polymorphism has earlier been reported to be 
associated with a number of autoimmune diseases (Albuquerque et al., 1998; Zelano et al., 
1998; Pandey et al., 1999; Vasku et al., 2000; Kula  et al., 2001; Lu et al., 2005; Takeuchi et al., 
2005; Panoulas et al.,  2008; Boraska et al., 2009; Watanabe et al.,  2010; Tiancha  et al., 2011) 
however, this is the first  report on the association between TNF-β polymorphism and 
glaucoma. The presence of allele G at +252 position defines the mutant allele also known as 
TNF-β* 1 (allele-1) is reported to be  associated with higher TNF-α and TNF-β production 
(Messer et al., 1991; Abraham et al., 1993). Therefore the higher frequencies of allele G and 
genotype GG of TNF-β (+252) along with  increased genotype GA of TNF-α (308) 
polymorphism might act in tandem to  increase TNF- α secretion in  ocular tissue of the 
patients that might lead to the development of glaucoma. 
Several studies have shown the relationships between increased TNF-ǂ levels and several 
ocular diseases including retinopathy (Doganay et al., 2002; Zorena et al., 2007).  Sugita et al. 
(2007) detected significantly elevated levels of TNF-ǂ and TNF-ǂ receptors in the ocular 
fluid of patients with active uveitis. In an animal model of high intraocular pressure, 
elevation of TNF-ǂ precedes the loss of retinal ganglion cells and oligodendrocytes. In 
addition, retinal cell degeneration has been observed by administering of TNF-ǂ even 
without the elevated intraocular pressure (Nakazawa et al., 2006). TNF-ǂ contributes to this 
process by adversely affecting oligodendrocytes (Butt & Jenkins,  1994)   which increases the 
susceptibility of axons to excitotoxicity in the optic nerve head and retinal ganglion cell death 
(Coleman, 2005). It has been observed that both mRNA and protein levels of TNF-ǂ or TNF-ǂ 
receptor-1 (TNF-R1) are raised in the retina of glaucomatous eyes as compared to normal eyes, 
and therefore it was suggested that cell death mediated by TNF-ǂ is a contributing factor in 
the neurodegeneration in glaucoma (Tezel et al., 2001). Using animal models, Nakazawa et al. 
(2006) showed that ocular hypertension or increased intraocular pressure induces TNF-ǂ 
upregulation in the retina, which in turn leads to RGC degeneration. It has also been observed 
that anti-TNF- ǂ antibodies can prevent death of RGCs suggesting that reducing the 
expression of TNF- ǂ would be beneficial in treating glaucoma.  
5. Conclusion  
This study clearly showed that the TNF-α  (-308) and TNF-β  (+252) polymorphisms are 
significantly associated with the susceptibility to primary glaucoma (POAG and PACG) in 
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Saudis and could be used as a genetic marker for disease mapping. To the best of our 
knowledge this is the first study showing an association of TNF-β  (+252) polymorphism 
with POAG and PACG. Immune hypotheses of glaucoma go very well with the findings of 
this study performed on the polymorphisms of TNF-ǂ and of TNF-β genes. These cytokines 
might play a crucial role in the signaling glaucomatous neurodegeneration. The TNF-ǂ (G-
308A) and TNF-β (A+252G) polymorphisms alter and modulate the production of cytokines 
such as TNF–α which is consistently proposed to be involved in the RGC degeneration. 
Moreover, TNF has been found to be associated with the regulation of glial cells and 
stimulation of the synthesis and secretion of nerve growth factors (NGF).Therefore 
understanding the role of gene polymorphism like TNF-α (-308) and TNF-β (+252) in 
various ethnic populations could be helpful in predicting the predisposition to glaucoma 
and might help in developing novel therapeutic strategies for the management of this 
disease.  
6. References 
Abraham, L.J. & Kroeger, K.M. (1999). Impact of the −308 TNF promoter polymorphism on 
the transcriptional regulation of the TNF gene: relevance to disease. Journal of 
Leukocyte Biology, 66, 562-566, ISSN 0741-5400 
Abraham, L.J., French, M.A.H. & Dawkins, R.L. (1993). Polymorphic MHC ancestral 
haplotypes affect the activity of tumour necrosis factor-alpha. Clinical & 
Experimental Immunology, 92, 14-18, ISSN 0009-9104 
Agarwal, P., Oldenburg, M.C., Czarneski, J.E., Morse, R.M., Hameed, M.R., Cohen, S. & 
Fernandes, H. (2000). Comparison study for identifying promoter allelic 
polymorphism in interleukin 10 and tumor necrosis factor alpha genes. Diagnostic 
Molecular Pathology, 9, 158-164, ISSN 1052-9551 
Albuquerque, R.V., Hayden, C.M., Palmer, L.J., Laing, I.A., Rye, P.J., Gibson, N.A., Burton, 
P.R., Goldblatt, J., Lesouef, P.N. (1998).Association of polymorphism within the 
tumour  necrosis factor (TNF) genes and childhood asthma. Clinical and 
Experimental Allergy, 28, 578-584, ISSN 0954-7894 
Allen, R.D. (1999). Polymorphism of the human TNF- ǂ promoter random variation or 
functional diversity? Molecular Immunology, 36, 1017-1027, ISSN  0161-5890 
Appropriateness of Treating Glaucoma Suspects RAND Study Group. (2009). For which 
glaucoma suspects is it appropriate to initiate treatment? Journal of Ophthalmology, 
116, 710-716, ISSN 2090-0058 
Arkell, S.M., Lightman, D.A., Sommer, A., Taylor, H.R., Korshin, O.M. & Tielsch J.M. (1987). 
The revalence of glaucoma among Eskimos of northwest Alaska. Archives of 
Ophthalmology, 105, 482-485, ISSN 0003-9950 
Aung, T., Lim, M.C., Wong, T.T., Thalamuthu, A., Yong, V.H., Venkataraman,D.,  
Venkataraman,  A., Chew, P.T., Vithana, E.N. (2008a). Molecular analysis of CHX10 
and MFRP in Chinese subjects with primary angle closure glaucoma and short axial 
length eyes. Molecular Vision, 14, 1313-1318, ISSN 1090-0535 
Aung, T., Victor, H.K., Lim, M.C., Venkataraman, D., Toh,  J.Y., Chew, P.T. &Vithana, E.N. 
(2008b). Lack of association between the rs2664538Polymorphism in the MMP-9 
www.intechopen.com
 The Mystery of Glaucoma 
 
246 
Gene and Primary angle Closure Glaucoma in Singaporean Subjects. Journal of 
Glaucoma, 17, 257-258, ISSN 1057-0829 
Ayub, H., Khan, M.I., Micheal, S., Akhtar, F., Ajmal, M., Shafique, S., Ali, S.H.B., Den 
Hollander, A.I., Ahmed ,A., Qamar, R. (2010). Association of eNOS and HSP70  
gene polymorphism with glaucoma in Pakistani cohorts. Molecular Vision , 16, 18-
25, ISSN 1090-0535 
Boraska, V., Zeggini, E., Groves, C.J., Rayner, N.W., Skrabic, V., Diakite, M., Rockett, K.A., 
Kwiatkowski, D., McCarthy, M.I. & Zemunik, T. (2009). Family based analysis of 
tumor necrosis factor and lymphotoxin-alpha Tag polymorphism with type 1 
diabetes in the population of South Croatia. Human Immunology, 70, 159-9, ISSN 
0198-8859 
Braun, N., Michel, U., Ernst, B.P., Metzner, R., Bitsch, A., Weber, F. & Riechmann, P. (1996). 
Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-
alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha 
production. Neuroscience Letters, 215, 75-78, ISSN  0304-3940 
Butt, A.M. & Jenkins, H.G. (1994). Morphological changes in oligodendrocytes in the intact 
mouse optic nerve following intravitreal injection of tumor necrosis factor. Journal 
of Neuroimmunology, 51,27–33, ISSN 0165-5728  
Cao, D., Lu, X., Guo X., Cong, Y., Huang, J. & Mao, Z. (2009). Investigation of the association 
between CALCRL polymorphisms and primary angle closure glaucoma. Molecular 
Vision, 15, 2202-2208, ISSN 1090-0535 
Casson, R.J., Newland, H.S., Muecke, J., McGrovern, S., Abraham, L., Shein, W.K., Selva, D. 
& Aung T. (2007).   Prevalence of glaucoma in rural Myanmar: the Meiktila Eye 
study. British Journal of Ophthalmology, 91, 710-714, ISSN 1468-2079 
Cedrone, C., Mancino, R., Cerulli, A., Cesareo, M. & Nucci, C. (2008). Epidemiology of 
primary glaucoma : prevalence, incidence, and blinding effects. Progress in Brain 
Research, 173, 3-14, ISSN 0079-6123  
Chakrabarti, S., Devi, K.R., Komatireddy, S., Kaur, K., Parikh, R.S., Mandal, A.K., 
Chandrasekhar, G. & Thomas, R. (2007). Glaucoma-Associated CYP1B1 mutations 
share similar haplotypes backgrounds in POAG and PACG phenotypes. 
Investigative Ophthalmology &Visual Science, 48, 5439-5444, ISSN  0146-0404 
Coleman, M. (2005). Axon degeneration mechanisms: commonality amid diversity. Nature 
Reviews Neuroscience, 6, 889–898, ISSN 1471-003X. 
Cong, Y., Guo, X., Liu, X., Cao, D., Jia, X., Xiao, X., Li, S., Fang, S. & Zhang, Q.(2009). 
Association of the single nucleotide polymorphisms in the extracellular matrix 
metalloprotease- 9 gene with PACG in southern China. MolecularVision, 15,1412-
1417, ISSN 1090-0535 
Cuenca, J., Perez, C., Aguirre, A., Schiattino, I. & Aguillon, J.C. (2001). Genetic 
polymorphism at position −308 in the promoter region of the tumor necrosis factor 
(TNF): implications of its allelic distribution on susceptibility or resistance to 
diseases in the Chilean population. Biological Research, 34, 237-241, ISSN 0716-97.  
Dai, X., Nie, S., Ke, T., Liu, J., Wang, Q. & Liu, M.(2008).Two variants in MYOC and CYP1B1 
genes in a Chinese family with primary angle closure glaucoma. Zhonghua Yi Xue 
Yi Chaun Xue Za Zhi, 25, 493-496, ISSN 1003-9406 
www.intechopen.com
Association of TNF-α and TNF-β Gene Polymorphisms  
with Primary Open Angle and Primary Angle Closure Glaucoma 
 
247 
Dandona, L., Dandona, R., Srinivas, M., Mandal, P., John, R.K., McCarty, C.A., et al. (2000). 
Open angle glaucoma in an urban population in southern India, the Andhra 
Pradesh eye disease study. Ophthalmology, 107, 1702-1709, ISSN  2090-004X  
Doganay, S., Evereklioglu, C.  Er, H., Türköz, Y, Sevinç , A., Mehmet, N. & Savli, H.  
(2002). Comparison of serum NO, TNF-ǂ, IL-1 , slL-2R, IL-6 and IL-8 levels with 
grades of retinopathy in patients with diabetes mellitus. Eye, 16,163–170, ISSN 0950-
222X 
Eid, T.M., El –Harwary, I. & El- Menawy, W. (2009). Prevalence of glaucoma types and legal 
blindness from glaucoma in the Western region of Saudi Arabia: a hospital based 
study. International Ophthalmology, 29, 477-483, ISSN 0165-5701. 
Ertel, W., Keel, M., Bonaccio, M., Steckholzer, U., Gallati, H., Kenney, J.S. & Trentz,O(1995). 
Release of anti-inflammatory mediators after mechanical trauma correlates with 
severity of injury and clinical outcome.  Journal of Trauma, 39, 879–887, ISSN 0022-
5282 
Fan, B.J., Liu, K., Wang, D.Y., Tham, C.C., Tam, P.O., Lam, D.S. & Pang, C.P. (2010). 
Association of polymorphisms of tumor necrosis factor and tumor protein p53 with 
primary open-angle glaucoma.  Investigative Ophthalmology & Visual Science, 51, 
4110-4116, ISSN 0146-0404 
Foster, P.J. & Johnson, G.J. (2001). Glaucoma in China: how big is the problem? British 
Journal of Ophthalmology, 85, 1277-1282, ISSN 0007-1161 
Foster, P.J., Oen, F.T., Machin, D., Ng, T.P., Devereux, J.G., Johnson, G.J., Khaw, P.T. & Seah, 
S.K. (2000). The prevalence of glaucoma in Chinese residents of Singapore: a cross- 
sectional population survey of the Tanjong Pagar district. Archives of Ophthalmology, 
118, 1105-1111, ISSN 0003-9950  
Foster, P.J., Buhrmann, R., Quigley, H.A. & Johnson, G.J. (2002). The definition and 
classification of glaucoma in prevalence surveys. British Journal of Ophthalmology, 
86, 238-242, ISSN 0007-1161 
Friedman, D.S., Jampel, H.D., Munoz, B. & West, S.K. (2006).The prevalence of open angle 
glaucoma among blacks and whites 73 years and older: the Salisbury eye 
evaluation glaucoma study. Archives of Ophthalmology,   124, 1625-1630, ISSN 0003-
9950 
Funayama, T., Ishikawa, K., Ohtake, Y., Tanino, T., Kurosaka, D., Kimura, I., et al.  
(2004).Variants in optineurin gene and their association with tumor necrosis factor-
alpha polymorphisms in Japanese patients with glaucoma. Investigative 
Ophthalmology & Visual Science, 45, 4359-4367, ISSN 0146-0404 
Galbratith, G.M. & Pendey, J.P. (1995). Tumor necrosis factor alpha (TNF-alpha) gene 
polymorphism in alopecia areata. Human Genetics, 96, 433-436, ISSN 0340-6717 
Green, C.M., Kearns, L.S., Wu, J., Barbour, J.M., Wilkinson, R.M., Ring, M.A., et al. (2007). 
How significant is a family history of glaucoma? Experience from the glaucoma 
inheritance study in Tasmania. Clinical & Experimental Ophthalmology, 35, 793 -799, 
ISSN 2155-9570 
Halpern, D.L. & Grosskreutz, C.L. (2002). Glaucomatous optic neuropathy: mechanisms of 
disease. Ophthalmology Clinics of North America, 15, 61-68, ISSN 0896-1549 
www.intechopen.com
 The Mystery of Glaucoma 
 
248 
He, M., Foster, P.J., Huang, W., Zheng, Y., Freidman, D.S, Lee, P.S. & Khaw, P.T. (2006). 
Prevalence and Clinical characteristics of Glaucoma in Adult Chinese: A population 
based study in Liwan District, Guangzhou. Investigative Ophthalmology & Visual 
Science, 47, 2782-2788, ISSN 0146-0404 
Hu, Z., Zhao, Z.L. & Dong, F.T. (1989). An epidemiological investigation of glaucoma in 
Beijing and Shun Yi county. Chinese Journal of Ophthalmology, 25, 115-118, ISSN 
0412-4081 
Huang, P., Zhang, S.S. & Zhang, C. (2009). The two sides of cytokine signaling and 
glaucomatous optic neuropathy. Journal of Ocular Biology, Diseases, and Informatics, 
2, 78-83, ISSN 1936-8437 
Jacob, A., Thomas, R., Koshi, S.P., Braganza, A. & Muliyil, J. (1998). Prevalence of primary 
glaucoma in an urban south Indian population. Indian Journal of Ophthalmology, 46, 
81-86, ISSN 0301-4738 
Jeong, P., Kim, E.J., Kim, E.G., Byun, S.S., Kim, C.S. & Kim, W.J. (2004). Association of 
bladder tumors and GA genotype of −308 nucleotide in tumor necrosis factor-alpha 
promoter with greater tumor necrosis factor-alpha expression. Urology, 64, 1052-
1056, ISSN 1677-5538 
Joachim, S.C., Wuenschig, D., Pfeiffer, N. & Grus, F.H. (2007). IgG antibody patterns in 
aqueous humor of patients with primary open angle glaucoma and 
psuedoexfoliation glaucoma. Moleuclar Vision, 13, 1573-1579, ISSN 1090-0535 
Khan, M.I., Michael, S., Akhtar, F., Naveed, A., Ahmed, A. & Qamar, R. (2009). Association 
of ABO blood groups with glaucoma in the Pakistani population. Canadian Journal 
of Ophthalmology, 44, 582-586, ISSN 1715-3360 
Kipnis, J., Mizrahi, T., Hauben, E., Shaked, I., Shevach, E., Schwartz, M. (2002). 
Neuroprotective autoimmunity: naturally occurring CD4+ CD25+ regulatory T 
cells suppress the ability to withstand injury to the central nervous system. 
Proceedings of the National Academy of Sciences, 99, 15620–15625, ISSN 0027-8424 
Klein, B.E., Klein, R., Sponsel, W.E., Frank ,T., Cantor, L.B., Martone, J. & Menage, M.J. 
(1992). Prevalence of glaucoma. The Beaver Dam Eye study. Journal of 
Ophthalmology, 99, 1499-1504, ISSN 2090-004X 
Kula, D., Jurecka-Tuleja, B., Gubala, E., Krawczyk, A., Szpak, S., Jarzab, M. (2001). 
Association of polymorphism of LT alpha and TNF genes with Graves disease. Folia 
Histochem Cytobiol, 39 Suppl 2: 77-8, ISSN 0258-851X  
Kwon, Y.H., Fingert, J.H., Kuehn, M.H. & Alward, W.L. (2009). Primary open angle 
glaucoma. New England Journal of Medicine, 360, 1113-1124, ISSN 0028-4793 
Laengle, U.W., Markstein, R., Pralet, D., Seewald, W. & Roman, D. (2006a). Effect of GLC756, 
a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor 
agonist, on TNF-alpha release in vitro from activated rat mast cells. Experimental 
Eye Research, 83, 1335-1339, ISSN 0014-4835 
Laengle, U.W., Trendelenburg, A.U., Markstein, R., Nogues, V., Provencher-Bollinger, A. & 
Roman, D. (2006b). GLC756 decreases TNF-alpha via an alpha2 and beta2 
adrenoceptor related mechanism. Experimental Eye Research, 83, 1246-1251, ISSN 
0014-4835 
www.intechopen.com
Association of TNF-α and TNF-β Gene Polymorphisms  
with Primary Open Angle and Primary Angle Closure Glaucoma 
 
249 
Leske, C., Connell, M., Wu, Y., Hyman, G. & Schachat, A.P. (1995). Risk factors for open-
angle glaucoma. The Barbados Eye Study. Archives of Ophthalmology, 113, 918-924, 
ISSN 0003-9950. 
Leske, M.C., Connell, A.M., Schachat, A.P.& Hyman, L. (1994). The Barbados Eye Study. 
Prevalence of Open Angle Glaucoma. Archives of Ophthalmology,112, 821-829, ISSN 
0003-9950 
Levkovitch-Verbin, H., Quigley, H. A., Martin K.R., Valenta ,D., Baumrind, L.A. & Pease, 
M.E. (2002). Translimbal laser photocoagulation to the trabecular meshwork as a 
model of glaucoma in rats. Investigative Ophthalmology & Visual Science, 43, 402-410, 
ISSN 0146-0404 
Levkovitch-Verbin, H., Quigley, H.A., Martin, K.R., Zack, D.J., Pease, M.E. & Valenta, D.F. 
(2003). A model to study differences between primary and secondary degeneration 
of retinal ganglion cells in rats by partial optic nerve transaction. Investigative 
Ophthalmology & Visual Science , 44, 3388-3393, ISSN 0146-0404  
Lilienbaum, A. & Israel, A. (2003). From calcium to NF-kappa B signaling pathways in 
neurons. Molecular and Cellular Biology, 23, 2680-2698. ISSN: 1098-5549 
Limb, G.A., Soomro, H., Janikoun, S., Hollifield, R.D.& Shilling J. (1999). Evidence for 
control of tumour necrosis factor –alpha(TNF-alpha) activity by TNF receptors in 
patients with proliferative diabetic retinopathy. Clinical and Experimental 
Immunology,  115, 409-414, ISSN 0009-9104 
Lin, H.J., Tsai, F.J., Chen, W.C., Shi, Y.R., Hsu, Y. & Tsai, S.W. (2003). Association of tumor 
necrosis factor alpha -308 gene polymorphism with primary open-angle glaucoma 
in Chinese. Eye, 17, 31-34, ISSN 0950-222X 
Liu, B. (2006).  Modulation of microglial pro-inflammatory and neurotoxic activity for the 
treatment of Parkinson’s disease. The American Association of Pharmaceutical 
Scientists Journal, 8, 606-621, ISSN 1550-7416 
Lowe, R.F. (1972). Primary angle-closure glaucoma. Inheritance and environment. British 
Journal of Ophthalmology, 56, 13-20, ISSN 0007-1161  
Lu, L.Y., Cheng, H.H., Sung, P.K., Tai, M.H., Yeh, J.J., Chen, A. (2005). Tumor necrosis  
factor –beta +252A polymorphism is associated with systemic lupus erythematosus 
in Taiwan. Journal of the Formosan Medical Association, 104, 563-570, ISSN   
0929-6646 
Määttä, M., Tervahartiala, T., Harju, M., Airaksinen, J., Autio-Harmainen, H. & Sorsa, T. 
(2005). Matrix metalloproteinases and their tissue inhibitors in aqueous humor of 
patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation 
glaucoma. Journal of Glaucoma, 14, 64-69, ISSN 1057-0829 
Marchetti, L., Klein, M., Schlett, K., Pfizenmaier, K. & Eisel, U.L. (2004). Tumor necrosis 
factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is 
enhanced by N-Methyl-D-aspartate receptor activation: Essential role of a TNF 
receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B 
pathway. Journal of Biological Chemistry, 279, 32869-32881, ISSN 0021-9258  
Mason, R.P., Kosoko, O., Wilson, M.R.,  et al. (1989).  National survey of the prevalence and 
risk factors of glaucoma in St. Lucia, West Indies. Part I. Prevalence findings. 
Ophthalmology, 96, 1363–1368, ISSN  2090-004X  
www.intechopen.com
 The Mystery of Glaucoma 
 
250 
McBrien ,N.A. & Gentle, A. (2001). Timp -2 regulation of MMP-2 activity during visually 
guided remodeling of the tree shrew sclera in lens-induced myopia. Investigative 
Ophthalmology & Visual, 42 Suppl: 314, ISSN: 0146-040 
Medcraft, J., Hitman, G.A., Sachs, J.A., Whichelow, C.E., Raafat, I. & Moore, R.H. (1993). 
Autoimmune renal disease and tumour necrosis factor beta gene polymorphism. 
Clinical Nephrology, 40, 63-68, ISSN  0301-0430 
Messer, G., Spengler, U., Jung, M.C., Honold, G., Biomer, K., Pape, G.R., et al. (1991). 
Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol 
Polymorphism in the first intron of the human TNF-beta gene correlates with a 
variant amino acid in position 26 and a reduced level of TNF-beta production. 
Journal of Experimental Medicine, 173, 209-219, ISSN:1540-9538 
Micheal, S., Qamar, R., Akhtar, F., Khan, W.A. & Ahmed, A. (2008). C677T polymorphism in 
the methylene tetrahydrofolate reductase gene is associated with primary closed 
angle glaucoma. Molecular Vision, 14, 661-5, ISSN 1090-0535 
Micheal, S., Qamar, R., Akhtar ,F., Khan, M.I, Khan, W.A. & Ahmed, A. (2009).MTHFR gene 
C677T and A1298C polymorphisms and homocystein levels in primary open angle 
and primary closed angle glaucoma. Molecular Vision, 15, 2268-2278, ISSN 1090-0535 
Mochizuki, M., Sugita, S., Ishikawa, N. & Wantanabe, T.(2000). Immunoregulation by 
aqueous humor. Cornea, 19, S24-5, ISSN: 0277-3740  
Mossbock, G., Weger, M., Moray, M., Renner, W., Haller-Schober, E.M., Mattes, D., Schmut, 
O., Wegscheider, B. & El-Shabrawi, Y. (2006). TNF-promoter polymorphisms and 
primary open-angle glaucoma. Eye, 20, 1040-1043, ISSN 0950-222X  
Mozaffarieh, M., Greishaber, M.C. & Flammer, J. (2008). Oxygen and blood flow: Players in 
the pathogenesis of glaucoma. Molecular Vision, 14, 224-233, ISSN 1090-0535 
Munoz-Fernandez, M.A., Fresno, M. (1998). The role of tumor necrosis factor, interleukin 6, 
interferon-  and inducible nitric oxide synthase in the development and pathology 
of the nervous system. Progress in Neurobiology,56, 307–340, ISSN 0301-0082  
Nakazawa, T., Nakazawa, C., Matsubara, A., Noda, K., Hisatomi, T., She, H., Michaud, N., 
Hafezi-Moghadam, A., Miller, J.W. & Benowitz, L.I. (2006). Tumor necrosis factor-
alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a 
mouse model of glaucoma. Journal of Neuroscience, 26, 12633-12641, ISSN 0270-6474. 
Niederkorn, J.Y. (2006). See no evil, hear no evil, do no evil: the lessons of immune privilege. 
Nature Immunology, 7, 354-359, ISSN 1529- 2908 
Pandey, J.P. & Takeuchi, F. (1999). TNF- alpha and TNF-beta gene polymorphism in 
systemic sclerosis. Human Immunology, 60, 1128-1130, ISSN 0198-8859 
Panoulas, V.F., Nikas, S.N., Smith, J.P.,Douglas, K.M., Nightingale, P.,Milionis, H.J., 
Treharne, G.J., Toms, T.E., Kita, M.D., Kitas, G.D. (2008). Lymphotoxin  252A>G  
polymorphism is common and associates with myocardial infarction in patients 
with Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 67, 1550-1556, ISSN 
0003-4967  
Papp, A.M., Nyilas, R., Szepesi, Z., Lorinez, M.L., Lorinez, M.L., Takacs, E., Abraham , I., 
Szilagyi, N., et al. (2007). Visible light induces matrix metalloprotinase-9 expression 
in rat eye. Journal of Neurochemistry ,103, 2224-2233, ISSN  0022-3042     
www.intechopen.com
Association of TNF-α and TNF-β Gene Polymorphisms  
with Primary Open Angle and Primary Angle Closure Glaucoma 
 
251 
Patino-Gracia, A., Sotillo- Pineiro, E., Modesto, C. & Sierrasesumaga, L. (2000). Analysis  
of the human tumour necrosis factor-alpha(TNF ǂ) gene promoter polymorphisms 
in children with bone cancer, Journal of Medical Genetics, 37, 789-792, ISSN  0148-
7299   
Pease, M.E., Mc Kinnon, S.J., Quigley, H.A., Kerrigan-Baumrind, L.A.  & Zack, D.J. (2000). 
Obstructed axonal transport of BDNF and its receptor TrkB in experimental 
glaucoma. Investigative Ophthalmology & Visual Science, 41, 764-774, ISSN  0146-0404 
Pekmezci, M., Vo, B., Lim, A.K., Hirabayashi, D.R., Tanaka, G.H., Weinreb, R.N. & Lin, S.C. 
(2009). The characteristics of Glaucoma in Japanese Americans. Archives of 
Ophthalmology , 127, 167-171, ISSN 0003-9950  
Perrey, C., Turney, S., Pravica, V., Howell, W.M. & Hutchinson, I.V. (1999). ARMS-PCR 
methodologies to determine IL-10, TNF-ǂ, TNF-ǃ and TGF-ǃ1 gene 
polymorphisms. Transplant Immunology, 7, 127-128, ISSN 0966-3274 
Quigley, H.A. & Broman, A.T. (2006). The number of people with glaucoma worldwide in 
2010 and 2020. British Journal of Ophthalmology, 90, 262-267, ISSN 1468-2079. 
Rajavashisth, T.B., Liao, J.K., Galis, Z.S., Tripathi, S., Laufs, U., Tripathi, J., Cahi, N.N., Xu, 
X.P., Jovinge, S., Shah, P.K. & Libby, P. (1999). Inflammatory cytokines and 
oxidized low density liproteins increase endothelial cell expression of membrane 
type 1-matrix metalloproteinase. Journal of Biological Chemistry, 274, 11924-11929, 
ISSN 0021-9258 
Razeghinejad, M.R., Rahat, F. & Kamali-Sarvestani, E. (2009). Association of TNFA −308 
G/A and TNFRI +36 A/G gene polymorphisms with glaucoma. Ophthalmic 
Research, 42, 118-124, ISSN 0030-3747 
Rotchford, A.P., Kirwan, J.F., Muller, M.A., Johnson, G.J. & Roux P. (2003). Temba glaucoma 
study: a population – based cross- sectional survey in urban South Africa. Journal of 
Ophthalmology, 110, 376-382,  ISSN 2090-004X 
Rotchford, A.P. & Johnson, G.J. (2002). Glaucoma in Zulus: a population –based cross 
sectional survey in a rural district in South Africa. Archives of Ophthalmology, 120, 
471-478, ISSN 0003-9950 
Sakata, K., Sakata, L.M., Sakata, V.M., Santini, C., Hopker, L.M., Bernardes,R., Yabumoto, C. 
& Moreira, A.T. (2007). Prevalence of Glaucoma in a South Brazilian Population: 
Projeto Glaucoma. Investigative Ophthalmology & Visual Science, 48, 4974-4979, ISSN  
0146-0404  
Savejgaard, A., Platz, P. & Ryder, L.P. (1983). HLA and disease-1982: a survey. Immunological 
Reviews, 70:193-218, ISSN 0105-2896  
Sawada, H., Fukuchi, T., Tanaka, T. & Abe, H. (2010). Tumor necrosis factor-alpha 
concentrations in the aqueous humor of patients with glaucoma. Investigative 
Ophthalmology & Visual Science, 51, 903-906, ISSN 0146-0404  
Schallreuter, K.U., Levenig, C., Kuhnl, P., Loliger, C., Hohl-Tehari, M. & Berger, J. (1993). 
Histocompatability antigens in vitiligo: Hamburg study on 102 patients from 
Northern Germany. Dermatology, 187, 186-192, ISSN 1167-1122   
Scheie, H.G. (1957). Width and pigmentation of the angle of the anterior chamber, a system 
of grading by gonioscopy. Archives of Ophthalmology American Medical Association, 
58, 510-512, ISSN 0096-6339  
www.intechopen.com
 The Mystery of Glaucoma 
 
252 
Schlötzer-Schrehardt, U., Lommatzsch, J., Kuchle, M., Konstas, A.G. & Naumann,  
G.O. (2003). Matrix metalloproteinases and their inhibitors in aqueous humor of 
patients with pseudoexfoliation syndrome/glaucoma and primary open-angle 
glaucoma. Investigative Ophthalmology & Visual Science, 44, 1117-1125, ISSN 0146-
0404   
Schwart, M. &  Kipnis, J. (2002). Autoimmunity on alert: naturally occurring regulatory 
CD4(+) CD25(+) T cells as part of the evolutionary compromise between a “need ” 
and a “risk ”. Trends in Immunology , 23, 530–534, ISSN 1471-4906 
Schwartz, M. & Kipnis,  J. (2001).  Protective autoimmunity: regulation and prospects for 
vaccination after brain and spinal cord injuries. Trends in Molecular Medicine, 7, 252–
258, ISSN 1471-4914 
Schwartz, M. (2007). Modulating the immune system: a vaccine for glaucoma. Canadian 
Journal of Ophthalmology, 42, 439-441, ISSN 1715-3360.  
Sharma, S., Ghosh, B. & Sharma, S.K. (2008). Association of TNF polymorphisms with 
sarcoidosis, its prognosis and tumour necrosis factor(TNF)-alpha levels in Asian 
Indians. Clinical & Experimental Immunology, 151,251-259, ISSN 0009-9104 
Sharma, S., Sharma, A., Kumar, S., Sharma, S.K. & Ghosh, B. (2006). Association of TNF 
haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha 
levels. American Journal of Respiratory Cell and Molecular Biology, 35, 488-495, ISSN 
1040-0605 
Shields, M.B. (2005). Shields’ Textbook of Glaucoma. 4th ed. Lippincott Williams and Wilkins 
publishers, ISBN 13: 978-1-60831-630-4 New York, USA 
Shohami, E., Bass, R., Wallach, D., Yamin, A. & Gallily, R. (1996). Inhibition of tumor 
necrosis factor alpha (TNF-ǂ) activity in rat brain is associated with 
cerebroprotection after closed head injury. Journal of Cerebral Blood Flow & 
Metabolism, 16, 378–384, ISSN 0271-678X 
Shohami, E., Ginis, I. & Hallenbeck, J.M. (1999). Dual role of tumor necrosis factor alpha in 
brain injury. Cytokine & Growth Factor, 10, 119-130, ISSN 1359- 6101 
Siwik, D.A., Chang, D.L. & Colucci, W.S. (2000). Interleukin-1 beta and tumor necrosis 
factor-alpha decrease collagen synthesis and increase matrix metalloproteinase 
activity in cardiac fibroblasts in vitro. Circulation Research, 86, 1259-1265, ISSN: 
0009-7330 
Spaeth, G.I. (1993). Direct Ophthalmoscopy, In: Varma, R., Spaeth, G.I., Parker, K.W., eds. The 
optic Nerve in Glaucoma, JB Lippincott Co, ISBN 0-397-51069-1, 127-135, 
Philadelphia, USA 
Stamenkovic, I.(2003). Extracellular matrix remodeling: the role of matrix 
metalloproteinases. Journal of Pathology, 200, 448-464, ISSN 0022-3417 
Sterilein, J.W. (2003). Ocular immune privilege: The eye takes a dim but practical view of 
immunity and inflammation. J Leukocyte Biology, 74, 179-85, ISSN 0741-5400 
Streilein, J.W. (1999). Immunoregulatory mechanisms of the eye. Progress in Retinal and Eye 
Research, 18,  357-370, ISSN  1350-9462 
Sugita, S., Takase, H., Taguchi, C. & Mochizuki, M. (2007). The role of soluble TNF receptors 
for TNF-alpha in uveitis. Investigative Ophthalmology & Visual Science, 48, 3246-3252, 
ISSN 0146-0404 
www.intechopen.com
Association of TNF-α and TNF-β Gene Polymorphisms  
with Primary Open Angle and Primary Angle Closure Glaucoma 
 
253 
Takeuchi,  F., Nabeta, H., Hong ,G.H., Kawasugi, K., Mori, M., Matsuta, K.,Kuwata, S., 
Murayama, T., Nakano, K. (2005).The genetic contribution of the TNFa11 
microsatellite allele  and  the TNFb +252*2 allele in Japanese RA. Clinical & 
Experimental Rheumatology, 23, 494-498, ISSN 0392-856X 
Tekeli, O., Turacli, M.E., Egin, Y., Akar, N. & Elhan, A.H. ( 2008). Tumor necrosis factor 
alpha-308 gene polymorphism and psuedoexfoliation glaucoma. Molecular Vision, 
14, 1815-1818, ISSN 1090-0535 
Tezel , G. & Wax, M.B. (2007). Glaucoma . Chemical Immunology and Allergy, 92, 221-227, 
ISSN: 1660-2242 
Tezel,  G.& Wax,  M.B. (2004). The immune system and glaucoma. Current Opinion in 
Ophthalmology ,15, 80–84, ISSN 1040-8738 
Tezel, G. & Wax,  M.B. (2003). Glial modulation of retinal ganglion cell death in glaucoma. 
Journal of Glaucoma, 12, 63–68, ISSN  1057-0829 
Tezel, G. & Yang, X. (2005). Comparative gene array analysis of TNF-alpha-induced MAPK 
and NF-kappaB signaling pathways between retinal ganglion cells and glial cells. 
Experimental Eye Research, 81, 207-217, ISSN 0014-4835 
Tezel, G. & Wax, M.B. (2000a). The mechanisms of hsp27 antibody-mediated apoptosis in 
retinal neuronal cells. Journal of Neuroscience, 20, 3552–3562, ISSN 0270-6474 
Tezel, G.& Wax, M.B. (2000b). Increased production of tumor necrosis factor-alpha by glial 
cells exposed to simulated ischemia or elevated hydrostatic pressure induces 
apoptosis in cocultured retinal ganglion cells. Journal of Neuroscience, 20, 8693–8700, 
ISSN 0270-6474 
Tezel, G., Edward, D. P. & Wax M.B.(1999).  Serum autoantibodies to optic nerve head 
glycosaminoglycans in patients with glaucoma. Archives of Ophthalmology, 117, 917–
924, ISSN 0003-9950 
Tezel, G., Li, L.Y., Patil, R.V. & Wax, M.B. (2001). TNF-alpha and TNF-alpha receptor-1 in 
the retina of normal and glaucomatous eyes. Investigative Ophthalmology & Visual 
Science , 42, 1787-1794, ISSN 0146-0404 
Tezel, G., Seigel, G.M. & Wax, M.B. (1998). Autoantibodies to small heat shock proteins in 
glaucoma. Investigative Ophthalmology & Visual Science, 39, 2277–2287, ISSN 0146-
0404 
Tezel, G., Yang, X., Yang, J. & Wax, M.B. (2004). Role of tumor necrosis factor receptor-1 in 
the death of retinal ganglion cells following optic nerve crush injury in mice. Brain 
Research, 996, 202–212, ISSN: 0006-8993 
Tiancha, H., Huiqin, W., Jiyong, J., Jingfen, J. & Wei, C. (2011). Association between 
lymphotoxin-? intron +252 polymorphism and sepsis: Ameta analysis. Scandinavian 
Journal of Infectious Diseases, 1-12, ISSN  0036-5548 
Tielsh, J.M., Sommer, A., Katz, J., Royall ,R.M., Quigley, H.A. & Javitt, J. (1991). Racial 
variation in prevalence of primary open angle glaucoma. Journal of the American 
Medical Association,266, 369-374, ISSN 0098-7484 
Tschumper, R.C. & Johnson, D.H. (1990). Trabecular meshwork cellularity: Differences 
between fellow eyes. Investigative Ophthalmology & Visual Science , 31, 1327-1331, 
ISSN 0146-0404 
www.intechopen.com
 The Mystery of Glaucoma 
 
254 
Uchida, M., Shima, M., Shimoaka, T., Fujieda, A., Obara, K., Suzuki, H., Nagai, Y., Ikeda, T., 
Yamato, H. & Kawaguchi, H. (2000). Regulation of matrix metalloproteinases 
(MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive 
factors in osteoblastic cells. Journal of Cellular Physiology ,185, 207-214, ISSN 0021-
9541 
Varma, R., Ying-Lai, M., Francis, B.A., Nguyen, B.B., Deneen, J., Wilson, M.R., Azen, S.P. & 
Los Angeles Latino Eye study group . (2004). Prevalence of open angle glaucoma 
and Ocular hypertension in Latinos:  the Los Angeles Latino eye study. Journal of 
Ophthalmology, 111, 1439-1448, ISSN 2090-004X 
Vasku, V., Vasku, A., Izakovicova Holla, L., Tschoplova, S., Kankova K, Benakova, N., 
Semradova, V. (2000). Polymorphism in inflammation genes (angiotensinogen, 
TAP1 and TNF-beta) in Psoriasis. Archives of Dermatological Research, 292, 531-534, 
ISSN 0340-3696 
Vijaya, L., George, R., Arvind, H., Baskaran, M., Ramesh, V., Raju,  P., Kumaramanickavel, 
G. & McCarty, C. (2008a). Prevalence of primary angle- closure disease in an urban 
South Indian population and comparison with a rular population. The Chennai 
glaucoma study. Journal of Ophthalmology, 115, 655-660, ISSN 2090-004X 
Vijaya, L., George, R., Baskaran, M. , Arvind, H., Raju,  P., Ramesh, V., Raju,  P., 
Kumaramanickavel, G., & McCarty, C. (2008b). Prevalence of primary open angle 
glaucoma  in an Urban South Indian population and comparison with a rural 
population. The Chennai glaucoma study. Journal of Ophthalmology, 115, 655-660, 
ISSN 2090-004X 
Wang, I.J., Chiang, T.H., Shih, Y.F., Lu, S.C., Lin, L.L., Shieh, J.W., Wang, T.H., Samples, J.R. 
& Hung PT.(2006). The association of single nucleotide polymorphisms in the 
MMP-9 genes with susceptibility to acute primary angle closure glaucoma in 
Taiwanese patients. Molecular Vision, 12, 1223-1232, ISSN 1090-0535 
Wantanabe, E., Buchman, T.G., Hirasawa, H., Zehnbauer, B.A. (2010). Association between 
lymphotoxin–ǂ (tumor necrosis factor-ǃ) intron polymorphism and predisposition 
to serve sepsis is modified by gender and age. Critical Care Medicine, 38,181-193, 
ISSN 0090-3493 
Wax, M.B. & Tezel, G. (2002).  Neurobiology of glaucomatous optic neuropathy: diverse 
cellular events in neurodegeneration and neuroprotection. Molecular Neurobiology, 
26, 45–55, ISSN 0893-7648 
Wax, M.B. (2000). Is there a role for the immune system in glaucomatous optic neuropathy? 
Current Opinion in Ophthalmology, 11, 145-150, ISSN 1040-8738 
Wax, M.B. & Tezel, G. (2009). Immunoregulation of retinal ganglion cell fate in glaucoma. 
Experimental Eye Research, 88,825–830,  ISSN 0014-4835 
Wax, M.B., Barrett, D.A. & Pestronk, A. (1994). Increased incidence of paraproteinemia and 
autoantibodies in patients with normal pressure glaucoma. American Journal of 
Ophthalmology, 117, 561–568, ISSN 0002-9394 
Wax, M.B., Tezel, G.& Edward, P.D. (1998a). Clinical and ocular histopathological findings 
in a patient with normal-pressure glaucoma. Archives of Ophthalmology, 116, 993–
1001, ISSN 0003-9950 
www.intechopen.com
Association of TNF-α and TNF-β Gene Polymorphisms  
with Primary Open Angle and Primary Angle Closure Glaucoma 
 
255 
Wax, M.B., Tezel, G., Saito, I., Gupta , R.S., Harley, J.B., Li, Z. & Romano,  C. (1998b). Anti-
Ro/SS-A positivity and heat shock protein antibodies in patients with normal-
pressure glaucoma. American Journal of Ophthalmology, 125,145–157, ISSN 0002-9394 
Wax, M.B., Yang, J. &  Tezel, G. (2001). Serum autoantibodies in patients with glaucoma. 
Journal of Glaucoma, 10, S22–24, ISSN 1057-0829 
Westendrop, R. G., Langermans, J.A., Huizinga, T.W., Elouali, A.H., Verweij, C.L., 
Boomsma, D.I. & Vandenbroucke, J.P. (1997). Genetic influence on cytokine 
production and fatal meningococcal disease. Lancet, 349, 170-173, ISSN 0140-6736 
Wilson, A.G., Di Giovine, F.S., Blakemore, A.I.F. & Duff, G.W. (1992). Single base 
polymorphism in the human tumor necrosis factor alpha (TNF-ǂ) gene detectable 
by Nco1 restriction of PCR product. Human Molecular Genetics, 1, 353, ISSN 0964-
6906 
Wilson, A.G., Gordon, C., di Giovine, F.S., de Vries, N., van de Putte, L.B., Emery, P. & Duff, 
G.W. (1994). A genetic association between systemic lupus erythematosus and 
tumor necrosis factor alpha. European Journal of Immunology, 24,  191-195, ISSN  
0014-2980 
Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O. & Duff, G.W. (1997). Effects of a 
polymorphism in the human tumor necrosis factor alpha promoter on 
transcriptional activation. Proceedings of the National Academy of Sciences of the United 
States of America ,94,  3195-3099, ISSN-0027-8424 
Wong, T.Y.,  Loon, S.C., Saw, S.M. (2006).The epidemiology of age related eye diseases in 
Asia. British Journal of Ophthalmology, 90, 506-511, ISSN 0007-1161 
Yan, X., Tezel, G., Wax, M.B. & Edward, P. (2000). Matrix metalloproteinases and tumor 
necrosis factor alpha in glaucomatous optic nerve head. Archives of Ophthalmology, 
118, 666–673, ISSN 0003-9950 
Yang,  J., Patil, R.V., Yu H., Gordon, M. & Wax, M.B. (2001a). T cell subsets and sIL-2R/IL-2 
levels in patients with glaucoma. American Journal of Ophthalmology, 131, 421–426, 
ISSN 0002-9394 
Yang, J., Tezel, G., Patil, R.V., Romano, C. & Wax, M.B. (2001b). Serum autoantibody against 
glutathione S-transferase in patients with glaucoma. Investigative Ophthalmology & 
Visual Science, 42, 1273–1276, ISSN 0146-0404  
Yoshioka, K., Yoshida, T., Takakura, Y., Umekawa, T., Kogure, A., Toda, H. & Yoshikawa, T. 
(2006). Relationship between polymorphisms 804C/A and 252A/G of 
lymphotoxin-alpha gene and  −308G/A of tumor necrosis factor alpha gene and 
diabetic retinopathy in Japanese patients with type 2 diabetes mellitus. Metabolism, 
55, 1406-1410, ISSN 0026-0494  
Yuan, L. & Neufeld, A.H. (2000). Tumor necrosis factor-alpha: a potentially 
neurodestructive cytokine produced by glia in the human glaucomatous optic 
nerve head. Glia, 32, 41-50, ISSN 1098-1136  
Yuan, L. & Neufeld, A.H. (2001). Activated microglia in the human glaucomatous optic 
nerve head. Journal of Neuroscience Research, 64, 523-532, ISSN 0360-4012 
Zelano, G., Lino, M.M., Evoli, A., Settesoldi, D., Batocchi,A.P., Torrente, I. & Tonali, P.A. 
(1998).Tumor necrosis factor beta gene polymorphism in myasthenia Gravis. 
European Journal of Immunogenetics, 25, 403-408, ISSN  0960 -7420  
www.intechopen.com
 The Mystery of Glaucoma 
 
256 
Zorena, K., Mysliwska, J., Mysliwec, M., Balcerska, A., Hak, L., Lipowski, P., & Raczynska 
K. (2007). Serum TNF-alpha level predicts non-proliferative diabetic retinopathy in 
children. Mediators of Inflammation, (92196), 1-5, ISSN 0962-9351 
www.intechopen.com
The Mystery of Glaucoma
Edited by Dr. Tomas Kubena
ISBN 978-953-307-567-9
Hard cover, 352 pages
Publisher InTech
Published online 06, September, 2011
Published in print edition September, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Since long ago scientists have been trying hard to show up the core of glaucoma. To its understanding we
needed to penetrate gradually to its molecular level. The newest pieces of knowledge about the molecular
biology of glaucoma are presented in the first section. The second section deals with the clinical problems of
glaucoma. Ophthalmologists and other medical staff may find here more important understandings for doing
their work. What would our investigation be for, if not owing to the people’s benefit? The third section is full of
new perspectives on glaucoma. After all, everybody believes and relies – more or less – on bits of hopes of a
better future. Just let us engage in the mystery of glaucoma, to learn how to cure it even to prevent suffering
from it. Each information in this book is an item of great importance as a precious stone behind which genuine,
through and honest piece of work should be observed.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Najwa Mohammed Al- Dabbagh, Nourah Al-Dohayan, Abdulrahman Al-Asmari, Misbahul Arfin and Mohammad
Tariq (2011). Association of TNF-alpha and TNF-beta Gene Polymorphisms with Primary Open Angle and
Primary Angle Closure Glaucoma, The Mystery of Glaucoma, Dr. Tomas Kubena (Ed.), ISBN: 978-953-307-
567-9, InTech, Available from: http://www.intechopen.com/books/the-mystery-of-glaucoma/association-of-tnf-
alpha-and-tnf-beta-gene-polymorphisms-with-primary-open-angle-and-primary-angle-c
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
